A study evaluating safety and efficacy of rivaroxaban discharge initiative in the treatment of acute venous thromboembolism

Trial Profile

A study evaluating safety and efficacy of rivaroxaban discharge initiative in the treatment of acute venous thromboembolism

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Sep 2017

At a glance

  • Drugs Rivaroxaban (Primary) ; Enoxaparin sodium; Warfarin
  • Indications Venous thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Sep 2017 New trial record
    • 02 Aug 2017 This initiative was started in late 2014 as per the results published in the American Journal of Emergency Medicine
    • 02 Aug 2017 Results published in the American Journal of Emergency Medicine
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top